Position in FULC
as of Mar 31, 2026
· filed May 7, 2026
Position Value
$8,669,253
-$3,218,957 QoQ
Shares Held
1,130,281
+7.5% QoQ
Ownership
1.70%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#21
of 168 holders
Holding Since
Mar 2021
21 quarters on record
Voting authority
Sole 88.49604655833372.ToString("F0")%
Shared 6.010806162361395.ToString("F0")%
None 5.493147279304881.ToString("F0")%
Common Shares in FULC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026DIMENSIONAL FUND ADVISORS LP holds $5,003,215,874 across 223 Biotechnology names. FULC ranks #81 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
989,342 | $441,780,774 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
513,060 | $396,410,676 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
1,895,215 | $358,290,394 | |
| 4 | BMRN |
Biomarin Pharmaceutical Inc
|
3,802,930 | $214,827,514 | |
| 5 | ROIV |
Roivant Sciences Ltd.
|
7,475,866 | $207,081,486 | |
| 6 | INCY |
Incyte Corp
|
1,975,544 | $185,938,199 | |
| 7 | EXEL |
Exelixis, Inc.
|
4,299,597 | $184,409,714 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
2,079,827 | $134,419,216 |
All Filings in FULC
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $8,669,253 | 1,130,281 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $11,888,210 | 1,051,124 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $11,953,632 | 1,299,308 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $9,443,740 | 1,372,637 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $4,052,299 | 1,407,049 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $6,667,841 | 1,418,690 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $5,081,875 | 1,423,495 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $9,181,739 | 1,480,926 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $12,317,423 | 1,304,812 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $6,583,132 | 975,279 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $2,495,270 | 561,998 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $1,568,605 | 475,335 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $2,151,424 | 754,886 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $2,816,136 | 386,832 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $1,893,706 | 234,080 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $1,774,309 | 362,104 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $6,688,054 | 282,793 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $3,317,246 | 187,521 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $1,431,601 | 50,748 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $792,109 | 75,583 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $586,820 | 49,815 | Shares | Defined | 2021-05-14 | |
| No filing history on record for this holder in this stock. | ||||||